This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignee: Abbott Laboratories Corporation. Active years: 1999-2006.
Company Filing History:
Years Active: 1999-2006
Title: Innovations of Stephen H Montgomery
Introduction
Stephen H Montgomery is a notable inventor based in Vernon Hills, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of erythromycin derivatives. With a total of five patents to his name, Montgomery's work has had a considerable impact on the treatment of bacterial infections.
Latest Patents
Montgomery's latest patents include a process for the 6-O-alkylation of erythromycin derivatives. This procedure involves preparing 6-O-alkyl erythromycin compounds through a reaction with an alkylating reagent in the presence of a strong alkali metal base and a weak organic amino base. The reaction occurs in a suitable stirred or agitated polar aprotic solvent, maintained at a specific temperature for a sufficient duration to effect alkylation. Another significant patent is for the preparation of a 6-O-alkyl derivative of 9-oxime erythromycin B, which includes intermediates used in the process. Additionally, he has developed pharmaceutical compositions containing these derivatives for treating bacterial infections.
Career Highlights
Montgomery is currently associated with Abbott Laboratories Corporation, where he continues to innovate in the pharmaceutical sector. His work has not only advanced the understanding of erythromycin derivatives but has also contributed to the development of effective treatments for various bacterial infections.
Collaborations
Montgomery has collaborated with notable colleagues, including Jih-Hua Liu and George A Foster, Jr. These collaborations have further enhanced the research and development efforts in his field.
Conclusion
Stephen H Montgomery's contributions to the field of pharmaceuticals through his innovative patents and collaborations have made a significant impact on the treatment of bacterial infections. His work continues to influence the industry and improve patient outcomes.